Functional Genomics Centre
The Joint AstraZeneca-CRUK Functional Genomics Centre offers researchers access to cutting-edge CRISPR technology to facilitate the creation of new cancer medicines and the improved use of existing cancer medicines.
Alongside the support and expertise the Functional Genomics Centre can bring to your projects, the Functional Genomics Centre will work with the cancer research community to deepen our understanding of the drivers behind cancer, reveal how resistance to treatments might arise and be avoided, and identify novel therapeutic approaches to traditionally hard-to-treat cancers.The facility will enable CRUK-funded researchers to pursue and translate ambitious science to benefit people affected by cancer.
We specialise in delivering pooled genome wide CRISPR screens. If you think your research could benefit from access to novel, state-of-the art CRIPSR technology we’d love to work with you to progress your research. Our expert team can help you plan your project to give you the best opportunity for success.
While we work with AstraZeneca to share resource and expertise within the Functional Genomics Centre, projects run by CRUK and arising data associated to these projects are independent and will remain unencumbered when entering the Functional Genomics Centre.